280
Participants
Start Date
July 7, 2022
Primary Completion Date
September 28, 2023
Study Completion Date
October 12, 2023
GW117 Tablets
GW117 Tablets 20mg orally once a day
GW117 Tablets
GW117 Tablets 20mg\*2 orally once a day
GW117 Tablets
GW117 Tablets 20mg\*3 orally once a day
Placebo
placebo orally once a day
Hebei Mental Health Center, Baoding
Beijing Huilongguan Hospital, Beijing
Capital Medical University Affliated Anding HospitalContact, Beijing
Peking University Sixth Hospital, Beijing
Chengdu No.4 People's Hospital, Chengdu
Chongqing Mental Health Center, Chongqing
The third hospital of Daqing, Daqing
Huzhou Third People's Hospital, Huzhou
Jilin Neuropsychiatric Hospital, Jilin
The Third People's Hospital of Mianyang City, Mianyang
Shanghai Mental Health Center, Shanghai
Shenzhen Kangning Hospital, Shenzhen
The First Hospital of Hebei Medical University, Shijiazhuang
Tianjin Anding Hospital, Tianjin
Wuxi Mental Health Center, Wuxi
Xijing Hospital, the Fourth Military Medical University, Xi'an, China, Xi'an
Zhumadian Second People's Hospital, Zhumadian
Beijing Greatway Pharmaceutical Technology Co.,Ltd.
INDUSTRY